MRI‐Based DeltaHabitat Radiomic Model Predicts Pathological Complete Response in Oral Cavity Cancer Treated With Neoadjuvant Chemoimmunotherapy
Cancer Medicine · 2026
DOI: 10.1002/cam4.72035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Lin Ding und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Mouth Neoplasms, Magnetic Resonance Imaging. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science Fund for Distinguished Young Scholars, Guangzhou Municipal Science and Technology Project, Medical Science and Technology Foundation of Guangdong Province.
Abstract (Originalsprache)
Objective
This study aimed to develop and validate an MRI‐based DeltaHabitat radiomics model to predict pathological complete response (pCR) in oral cavity squamous cell carcinoma (OCSCC) patients treated with neoadjuvant chemoimmunotherapy.
Methods
Patients treated with neoadjuvant chemoimmunotherapy and surgery were retrospectively included from one institution and randomly divided into training and test cohorts using a 7:3 ratio. The region of interest (ROI) for the primary tumor was manually delineated on contrast‐enhanced T1‐weighted MRI, and radiomic features were extracted. The volume of interest was segmented into three subregions using the K‐means clustering algorithm. Following feature selection, five models were constructed to predict pCR in both the training and test cohorts. The efficacy of the models was evaluated using receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA).
Results
One hundred and ninety‐five patients were enrolled. The median age was 57 years, and 127 (65.1%) patients were male. Features were extracted from three separate regions, and a total of 5502 features were yielded. After the feature selection process, 12 features were retained. Among radiomic models, the DeltaHabitat model demonstrated a satisfactory area under the receiver operating characteristic curve (AUC) in both the training and test cohorts (0.923, 95% CI: 0.880–0.967; 0.878, 95% CI: 0.791–0.964, respectively).
Conclusion
MRI‐based DeltaHabitat radiomics model demonstrated good performance in predicting pCR in OCSCC patients treated with neoadjuvant chemoimmunotherapy. This non‐invasive approach may facilitate early identification of responders and support individualized treatment decision‐making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
- Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen Universi…
- Department of Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
ORCID-Profile: Changlong Chen
Förderung
- National Science Fund for Distinguished Young Scholars
- Guangzhou Municipal Science and Technology Project
- Medical Science and Technology Foundation of Guangdong Province
Zitieren
APA
Ding, L., Wu, J., Liang, Y., Ding, J., Zhou, S., Li, L., Lin, L., Zeng, J., & Chen, C. (2026). MRI‐Based DeltaHabitat Radiomic Model Predicts Pathological Complete Response in Oral Cavity Cancer Treated With Neoadjuvant Chemoimmunotherapy. Cancer Medicine. https://doi.org/10.1002/cam4.72035
Vancouver
Ding L, Wu J, Liang Y, Ding J, Zhou S, Li L, et al. MRI‐Based DeltaHabitat Radiomic Model Predicts Pathological Complete Response in Oral Cavity Cancer Treated With Neoadjuvant Chemoimmunotherapy. Cancer Medicine. 2026. doi:10.1002/cam4.72035
BibTeX
@article{Ding2026,
author = {Ding, Lin and Wu, Jialing and Liang, Yangxin and Ding, Jiaxuan and Zhou, Shu and Li, Liting and Lin, Lehang and Zeng, Jiale and Chen, Changlong},
title = {MRI‐Based DeltaHabitat Radiomic Model Predicts Pathological Complete Response in Oral Cavity Cancer Treated With Neoadjuvant Chemoimmunotherapy},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.72035}
}
EUVIMED